Fibroblast proliferation by bleomycin stimulated peripheral blood mononuclear cell factors

Journal of Rheumatology

Volumn 26, Issue 3, 1999, Pages 609-615

  Yamamoto, Toshiyuki ^a   Katayama, Ichiro ^b   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Bleomycin; Cytokine; Fibroblasts; Macrophages; RT PCR; Scleroderma

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BLEOMYCIN; CYTOKINE; CYTOKINE ANTIBODY; GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN 3T3; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE;

3T3 CELLS; ADULT; AGED; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, BLOCKING; BLEOMYCIN; CELL DIVISION; CULTURE MEDIA, CONDITIONED; CYTOKINES; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MIDDLE AGED; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCLERODERMA, SYSTEMIC;

EID: 0033020912     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fishman S, Russo GG. The toxic pseudosclerodermas. Int J Dermatol 1991;30:837-42.
2. Varga J, Jimenez SA. Chemical exposure-induced cutaneous fibrosis. Arch Dermatol 1994;130:97-100.
3. Cohen IS, Mosher MB, O'Keefe EJ, Klaus SN, de Conti RC. Cutaneous toxicity of bleomycin therapy. Arch Dermatol 1973;107:553-5.
4. Finch WR, Rodnan GP, Buckingham RB, Prince RK, Winkelstein A. Bleomycin induced scleroderma. J Rheumatol 1980;7:651-9.
5. Nixon DW, Pirozzi D, York RM. Dermatologic changes after systemic cancer therapy. Cutis 1981;27:181-94.
6. Adamson IY, Bowden DH. The pathogenesis of bleomycin induced pulmonary fibrosis in mice. Am J Pathol 1974:77:185-98.
7. Mountz JD, Downs Minor MB, et al. Bleomycin-induced cutaneous toxicily in the rat: analysis of histopathology and ultrastructure compared with progressive systemic sclerosis (scleroderma). Br J Dermatol 1983;108:679-86.
8. Goto T, Befus D, Low R, Bienenstock J. Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats. Am Rev Respir Dis 1984;130:797-802.
9. Denholm EM, Phan SH. The effects of bleomycin on alveolar macrophage growth factor secretion. Am J Pathol 1989;134:355-63.
10. Kovacs EJ, Kelley J. Secretion of macrophage-derived growth factor during acute lung injury by bleomycin. J Leukocyte Biol 1985;37:1-14.
11. Martinet YM, Rom WN, Grotendrost GR, Martin GR, Crystal RG. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med 1987;317:202-9.
12. Phan SH, McGarry BM, Loeffler KM, Kunkel SL. Regulation of macrophage derived fibroblast growth factor release by arachidonate metabolites. J Leukocyte Biol 1987;42:106-13.
13. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vissalli P. Tumor necrosis factor-α/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 1989;170:655-63.
14. Piguet PF, Collart MA, Grau GE, Sappino AP, Vissalli P. Requirement of human tumor necrosis factor for the development of silica-induced pulmonary fibrosis. Nature 1990;344:245-7.
15. Rom WN, Basset P, Fells GA, Nukiwa T, Trapnell BC, Crystal RG. Alveolar macrophages release an insulin-like growth factor 1-type molecule. J Clin Invest 1988;82:1685-93.
16. Julius MH, Simpson E, Herzenberg LA. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 1973;3:645-9.
17. Suwabe A, Takahashi K, Yasui S, et al. Bleomycin-stimulated hamster alveolar macrophages release interleukin 1. Am J Pathol 1988;132:512-20.
18. Cutroneo K, Breen E, Absher M, Phan SH. Bleoraycin regulation of transforming growth factor-ß mRNA in rat lung fibroblasts and subpopulations. Chest 1991;99:65S-6S.
19. Smith RE, Stricter RM, Phan SH, et al. Production and function of murine macrophage inflammatory protein-1α in bleomycin-induced lung injury. J Immunol 1994;153:4704-12.
20. Zhang K, Kathleen C, Flanders C, Phan SH. Cellular localization of transforming growth factor-B expression in bleomycin-induced pulmonary fibrosis. Am J Pathol 1995;147:352-61.
21. Khalil N, Bereznay O, Sporn M, Greenberg A. Macrophage production of transforming growth factor and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989;170:727-37.
22. Coker RK, Laurent GJ, Shahzeidi S, et al. Transforming growth factor-ß1, -ß2, and -ß3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 1997;150:981-91.
23. Postlethwaite AE, Kang AH. Induction of fibroblast proliferation by human mononuclear leukocyte-derived proteins. Arthritis Rheum 1983;26:22-7.
24. Worrall JG, Whiteside TL, Prince RK, Buckingham RB, Stachura I, Rodnan GP. Persistence of scleroderma-like phenotype in normal fibroblasts after prolonged exposure to soluble mediators from mononuclear cells. Arthritis Rheum 1986;29:54-64.
25. Thornton SC, Walsh BJ, Bennett S, et al. Both in-vitro and in vivo irradiation are associated with induction of macrophage-derived fibroblast growth factors. Clin Exp Immunol 1996;1093:67-73.
26. Shimokado K, Raines EW, Madtes DK, et al. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 1985;43:277-86.
27. Jordana M, Richards C, Irving LB, Gauldie J. Spontaneous in vitro release of alveolar-macrophage cytokines after the intratracheal instillation of bleomycin in rats. Am Rev Respir Dis 1988;137:1135-40.
28. Goldring MB, Krane SM. Modulation by recombinant interleukin 1 of synthesis of type I and III collagens and associated procollagen mRNA levels in cultured human cells. J Biol Chem 1987;262:16724-9.
29. Postlethwaite AE, Raghow R, Stricklin GP, et al. Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type 1 procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 α and ß. J Cell Biol 1988;106:11-8.
30. Schmidt JA, Mizel SB, Cohen D, et al. Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol 1982;128:2177-82.
31. Battegay EJ, Raines E, Colbert T, Ross R. TNF-α stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. J Immunol 1995;154:6040-7.
32. Maeda A, Hiyama K, Yamakido H, Ishioka S, Yamakido M. Increased expression of platelet-derived growth factor A and insulin-like growth factor-I in BAL cells during the development of bleomycin-induccd pulmonary fibrosis in mice. Chest 1996;109:780-6.
33. Liebler J, Picou MA, Qu Z, Powers MR, Rosenbaum JT. Altered immunohistochemical localization of basic fibroblast growth factor after bleomycin-induced lung injury. Growth Factors 1997;14:25-38.
34. Feghali CA, Bost KL, Boulware DW, Levy LS, Mechanisms of pathogenesis in scleroderma. I. Over-expression of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol 1992;19:1207-11.
35. Kadono T, Kikuchi K, Ihn H, Takehara K, Tamaki K. Increased production of interleukin 6 and inlerleukin 8 in scleroderma fibroblasts. J Rheumatol 1998;25:296-301.
36. Elias JA, Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol 1990;145:161-6.